NDC 0264-1965

HESPAN

Hetastarch In Sodium Chloride

HESPAN is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Hetastarch; Sodium Chloride.

• Product ID: 0264-1965_47e5d437-857d-4328-bdda-e6ff01544d9d
• NDC: 0264-1965
• Product Type: Human Prescription Drug
• Proprietary Name: HESPAN
• Generic Name: Hetastarch In Sodium Chloride
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1991-04-04
• Marketing Category: NDA / NDA
• Application Number: BN890105
• Labeler Name: B. Braun Medical Inc.
• Substance Name: HETASTARCH; SODIUM CHLORIDE
• Active Ingredient Strength: 6 g/100mL; g/100mL
• Pharm Classes: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0264-1965-10

12 CONTAINER in 1 CASE (0264-1965-10) > 500 mL in 1 CONTAINER

• Marketing Start Date: 1991-04-04
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0264-1965-10 [00264196510]

HESPAN INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: BN890105
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1991-04-04

Drug Details

Active Ingredients

Ingredient	Strength
HETASTARCH	6 g/100mL

OpenFDA Data

• SPL SET ID: 6f90664e-f2ec-47ea-bfec-7be2bf2dc28c
• Manufacturer:
  • B. Braun Medical Inc.
• UNII:
  • 875Y4127EA
  • 451W47IQ8X
• RxNorm Concept Unique ID - RxCUI:
  • 310757
  • 809605

Pharmacological Class

• Plasma Volume Expander [EPC]
• Increased Intravascular Volume [PE]
• Osmotic Activity [MoA]
• Starch [CS]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Plasma Volume Expander [EPC]
• Increased Intravascular Volume [PE]
• Osmotic Activity [MoA]
• Starch [CS]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]